Progress of research on the role of peritoneal dialysis in treatment of cardiorenal syndrome type Ⅰand Ⅱ

Shu Li,Zhaohui Ni

DOI: https://doi.org/10.3877/cma.j.issn.2095-3216.2014.03.009

2014-01-01

Abstract:Cardiorenal syndrome (CRS ) is defined as a complex pathophysiological disorder manifested by both cardiac and renal dysfunctions with a high mobidity and a very complicated therapy.To alleviate the symptoms of congestive heart failure in patients with CRS typeⅠand Ⅱ,diuretics and ultrafiltration are usually used in traditional therapy,although both of them have their limitations.In recent years,accumulating studies have indicated that peritoneal dialysis (PD)is an effective therapy in fluid removal,cardiac function improvement,and hospitalization reduction of patients with CRS typeⅠand Ⅱ. The present review mainly introduces the results of recent studies of PD therapy in CRS typeⅠandⅡ,with an emphasis on the efficacy,underlying mechanisms,and feasibility of PD.